Chemistry - A European Journal · 2020 · 10 citations · 46 references
Life SciencesBiochemistryImmunologyDrug DiscoveryGlycobiologyInnate ImmunityC-type Lectin ReceptorsGlycan BiosynthesisGlycan RecognitionGlycan StructureN-linked GlycosylationO-linked GlycosylationCarbohydrate Recognition DomainsCarbohydrate Recognition MotifsLectin InteractionsLectin-carbohydrate RecognitionLectin-glycan Interactions In CancerMucin BiologyO-glycan RecognitionParasitic Stages
Due to their interactions with C-type lectin receptors (CLRs), glycans from the helminth Schistosoma mansoni represent promising leads for treatment of autoimmune diseases, allergies or cancer. We chemo-enzymatically synthesized nine O-glycans based on the two predominant O-glycan cores observed in the infectious stages of schistosomiasis, the mucin core 2 and the S. mansoni core. The O-glycans were fucosylated next to a selection of N-glycans directly on a microarray slide using a recombinant fucosyltransferase and GDP-fucose or GDP-6-azidofucose as donor. Binding assays with fluorescently labelled human CLRs DC-SIGN, DC-SIGNR and MGL revealed the novel O-glycan O8 as the best ligand for MGL from our panel. Significant binding to DC-SIGN was also found for azido-fucosylated glycans. Contrasting binding specificities were observed between the monovalent carbohydrate recognition domain (CRD) and the tetravalent extracellular domain (ECD) of DC-SIGNR.
46
Ellis van Liempt, Sandra J. van Vliet, Anneke Engering et al. · Molecular Immunology · 2007 · 250 citations
Sandra J. van Vliet, Ellis van Liempt, Eiríkur Saeland et al. · International Immunology · 2005 · 235 citations · Full text